This document is an excerpt from the EUR-Lex website
Document 62023TA0520
Case T-520/23: Judgment of the General Court of 18 December 2024 – Hecht Pharma v EUIPO – Gufic BioSciences (H 15 Gufic) (EU trade mark – Revocation proceedings – EU figurative mark H 15 Gufic – Genuine use of a mark – Article 58(1)(a) of Regulation (EU) 2017/1001 – Public and outward use – Use in connection with the goods in respect of which the mark was registered)
Case T-520/23: Judgment of the General Court of 18 December 2024 – Hecht Pharma v EUIPO – Gufic BioSciences (H 15 Gufic) (EU trade mark – Revocation proceedings – EU figurative mark H 15 Gufic – Genuine use of a mark – Article 58(1)(a) of Regulation (EU) 2017/1001 – Public and outward use – Use in connection with the goods in respect of which the mark was registered)
Case T-520/23: Judgment of the General Court of 18 December 2024 – Hecht Pharma v EUIPO – Gufic BioSciences (H 15 Gufic) (EU trade mark – Revocation proceedings – EU figurative mark H 15 Gufic – Genuine use of a mark – Article 58(1)(a) of Regulation (EU) 2017/1001 – Public and outward use – Use in connection with the goods in respect of which the mark was registered)
OJ C, C/2025/912, 17.2.2025, ELI: http://data.europa.eu/eli/C/2025/912/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
Official Journal |
EN C series |
|
C/2025/912 |
17.2.2025 |
Judgment of the General Court of 18 December 2024 – Hecht Pharma v EUIPO – Gufic BioSciences (H 15 Gufic)
(Case T-520/23) (1)
(EU trade mark - Revocation proceedings - EU figurative mark H 15 Gufic - Genuine use of a mark - Article 58(1)(a) of Regulation (EU) 2017/1001 - Public and outward use - Use in connection with the goods in respect of which the mark was registered)
(C/2025/912)
Language of the case: German
Parties
Applicant: Hecht Pharma GmbH (Bremervörde, Germany) (represented by: C. Sachs and J. Sachs, lawyers)
Defendant: European Union Intellectual Property Office (represented by: A. Ringelhann, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Gufic Biosciences Ltd. (Mumbai, India) (represented by: A. Wehlau and T. Uhlenhut, lawyers)
Re:
By its action based on Article 263 TFEU, the applicant seeks the annulment and the alteration of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 13 June 2023 (Case R 902/2021-2).
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Hecht Pharma GmbH to pay the costs. |
ELI: http://data.europa.eu/eli/C/2025/912/oj
ISSN 1977-091X (electronic edition)